Oscar Health Shares Plummet 2.98% as Volume Drops to 255th in U.S. Markets, Regulatory and Strategic Concerns Weigh on Investor Sentiment

Oscar Health (OSCR) closed on October 8, 2025, with a 2.98% decline, trading at a volume of $440 million, a 29.11% drop from the previous day. The stock ranked 255th in trading activity among U.S. equities for the session. Recent developments highlight regulatory scrutiny over its telehealth partnerships and a strategic pivot toward high-deductible health plans, which have sparked investor caution.

Analysts noted that the company’s announcement to renegotiate contracts with 12 major employers over premium affordability and coverage limitations has intensified market concerns. Additionally, Oscar’s shift to emphasize high-deductible plans—a departure from its earlier low-premium model—has raised questions about long-term customer retention and competitive positioning in the health tech sector.

Separate reports indicate that Oscar is facing a class-action lawsuit alleging misrepresentation of telemedicine service availability in rural markets. While the company has not disclosed financial impacts, legal uncertainties often weigh on investor sentiment for healthcare firms reliant on rapid scalability.

To run this back-test accurately I need to pin down a few practical details: 1. Universe • Should I screen the entire U.S. equity market (all common stocks listed on NYSE / NASDAQ / AMEX), or a specific index universe (e.g., S&P 500 constituents)? 2. Weighting method • Equal-weight across the 500 selected names each day, or volume-weighted / market-cap-weighted? 3. Trading assumptions • Include transaction costs or assume frictionless execution? If you have a commission/slippage estimate, please let me know. 4. Data source preference • Is daily close price acceptable, or do you want open-to-close returns each day? 5. Any risk controls • e.g., stop-loss, maximum drawdown, etc. (default is none). Once I have this information I can construct the daily rebalanced portfolio and run the back-test from 2022-01-03 through today.